LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 292 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,023,000 | -18.5% | 8,135 | -12.1% | 0.31% | -31.2% |
| Q4 2018 | $1,255,000 | -54.2% | 9,250 | -7.3% | 0.45% | -38.2% |
| Q3 2018 | $2,739,000 | +33.8% | 9,980 | +1.0% | 0.72% | +28.7% |
| Q2 2018 | $2,047,000 | +95.0% | 9,880 | +55.3% | 0.56% | +92.8% |
| Q1 2018 | $1,050,000 | +118.8% | 6,360 | +81.5% | 0.29% | +117.2% |
| Q4 2017 | $480,000 | -79.8% | 3,505 | -79.9% | 0.13% | -81.1% |
| Q3 2017 | $2,376,000 | +120.4% | 17,455 | +96.6% | 0.71% | +101.7% |
| Q2 2017 | $1,078,000 | – | 8,880 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |